Kwality Pharmaceuticals Limited (BOM:539997)
3,671.45
+41.80 (1.15%)
At close: Sep 25, 2026
Kwality Pharmaceuticals Earnings Call Transcripts
Fiscal Year 2027
-
Revenue guidance for FY 2027 is raised to over INR 700 crore with EBITDA margins of 26%-27%, driven by new product registrations and expansion in LATAM and MENA regions. Major CapEx is planned for hormone, oncology, and biosimilar programs, with strong growth expected through FY 2030.